Is Myomo, Inc. (MYO) a Buy, Sell, or Hold?
AMEX : MYO
Myomo, Inc. — Insider Trades
$1.42 USD
$0.11 (8.4%)
- Volume
- 1.1M
- Average Volume
- 760.16K
- Market Capitalization
- $54.87M
- P/E Ratio
- -4.17
- Dividend Yield
- 0.00%
- Price Target
- $1.10
- Year High
- $1.99
- Year Low
- $0.61
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.31
Insider Activity Summary (Last 12 Months)
Insiders Buying
27
Insiders Selling
11
Amount of Insider Selling
$186.04K
MYO Insider Buying/Selling by Quarter
MYO Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| HENRY DAVID A | officer: Chief Financial Officer | 2026-07-10 | A-Award | 0 | 2026-07-13 |
| HENRY DAVID A | officer: Chief Financial Officer | 2026-07-13 | F-InKind | 1.09 | 2026-07-13 |
| GUDONIS PAUL R | director, officer: Chief Executive Officer | 2026-07-10 | A-Award | 0 | 2026-07-13 |
| Manko Joseph M. Jr. | director | 2026-06-25 | A-Award | 0 | 2026-06-26 |
| Crowley Thomas Aloysius Jr. | director | 2026-06-25 | A-Award | 0 | 2026-06-26 |
| KIRK THOMAS F | director | 2026-06-25 | A-Award | 0 | 2026-06-26 |
| Getz Heather C | director | 2026-06-25 | A-Award | 0 | 2026-06-26 |
| FEBBO WILLIAM J | director | 2026-06-25 | A-Award | 0 | 2026-06-26 |
| Morris Milton Mayo | director | 2026-06-25 | A-Award | 0 | 2026-06-26 |
| Kovelman Harry | officer: Chief Medical Officer | 2026-06-12 | F-InKind | 1.2 | 2026-06-12 |
| Mitchell Micah | officer: Chief Commercial Officer | 2026-06-12 | F-InKind | 1.2 | 2026-06-12 |
| HENRY DAVID A | officer: Chief Financial Officer | 2026-06-12 | F-InKind | 0 | 2026-06-12 |
| Mitchell Micah | officer: Chief Commercial Officer | 2026-06-08 | F-InKind | 1.33 | 2026-06-09 |
| Kovelman Harry | officer: Chief Medical Officer | 2026-06-08 | F-InKind | 1.33 | 2026-06-09 |
| HENRY DAVID A | officer: Chief Financial Officer | 2026-06-08 | F-InKind | 0 | 2026-06-09 |
| KIRK THOMAS F | director | 2026-06-05 | P-Purchase | 1.27 | 2026-06-09 |
| Mitchell Micah | officer: Chief Commercial Officer | 2026-05-14 | S-Sale | 0.861 | 2026-06-08 |
| KIRK THOMAS F | director | 2026-05-28 | P-Purchase | 0.993 | 2026-06-01 |
| Kovelman Harry | officer: Chief Medical Officer | 2026-05-27 | S-Sale | 1.002 | 2026-05-28 |
| Kovelman Harry | officer: Chief Medical Officer | 2026-05-28 | S-Sale | 1.0172 | 2026-05-28 |
| KIRK THOMAS F | director | 2026-05-18 | P-Purchase | 0.91 | 2026-05-18 |
| KIRK THOMAS F | director | 2026-05-15 | P-Purchase | 0.9096 | 2026-05-18 |
| Manko Joseph M. Jr. | director | 2026-05-15 | P-Purchase | 0.8878 | 2026-05-18 |
| Manko Joseph M. Jr. | director | 2026-05-14 | P-Purchase | 0.8602 | 2026-05-18 |
| Manko Joseph M. Jr. | director | 2026-05-09 | 0 | 2026-05-18 | |
| Mitchell Micah | officer: Chief Commercial Officer | 2025-05-14 | S-Sale | 0.861 | 2026-05-15 |
| FEBBO WILLIAM J | director | 2026-04-14 | A-Award | 0 | 2026-04-16 |
| FEBBO WILLIAM J | 2026-04-14 | 0 | 2026-04-16 | ||
| GUDONIS PAUL R | director, officer: Chief Executive Officer | 2026-04-10 | A-Award | 0 | 2026-04-14 |
| HENRY DAVID A | officer: Chief Financial Officer | 2026-04-10 | A-Award | 0 | 2026-04-14 |
| HENRY DAVID A | officer: Chief Financial Officer | 2026-04-13 | F-InKind | 0.71 | 2026-04-14 |
| GUDONIS PAUL R | director, officer: Chief Executive Officer | 2026-04-10 | A-Award | 0 | 2026-04-14 |
| Getz Heather C | director | 2026-03-16 | P-Purchase | 0.6986 | 2026-03-17 |
| KIRK THOMAS F | director | 2026-03-13 | P-Purchase | 0.7099 | 2026-03-16 |
| Getz Heather C | director | 2026-03-12 | P-Purchase | 0.728 | 2026-03-12 |
| GUDONIS PAUL R | director, officer: Chief Executive Officer | 2026-01-12 | A-Award | 0 | 2026-01-14 |
| HENRY DAVID A | officer: Chief Financial Officer | 2026-01-12 | A-Award | 0 | 2026-01-14 |
| KIRK THOMAS F | director | 2025-11-21 | P-Purchase | 0.72 | 2025-11-24 |
| KIRK THOMAS F | director | 2025-11-20 | P-Purchase | 0.72 | 2025-11-24 |
| Crowley Thomas Aloysius Jr. | director | 2025-11-18 | P-Purchase | 0.7345 | 2025-11-21 |
| Crowley Thomas Aloysius Jr. | director | 2025-11-19 | P-Purchase | 0.765 | 2025-11-21 |
| GUDONIS PAUL R | director, officer: Chief Executive Officer | 2025-09-09 | G-Gift | 0 | 2025-09-11 |
| KIRK THOMAS F | director | 2025-08-25 | P-Purchase | 1.15 | 2025-08-26 |
| KIRK THOMAS F | director | 2025-08-18 | P-Purchase | 1.1 | 2025-08-19 |
| GUDONIS PAUL R | director, officer: Chief Executive Officer | 2025-08-15 | P-Purchase | 0.9459 | 2025-08-18 |
| Kovelman Harry | officer: Chief Medical Officer | 2025-06-30 | F-InKind | 2.19 | 2025-07-02 |
| HENRY DAVID A | officer: Chief Financial Officer | 2025-06-30 | F-InKind | 2.19 | 2025-07-02 |
| Kovelman Harry | officer: Chief Medical Officer | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| Mitchell Micah | officer: Chief Commercial Officer | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| HENRY DAVID A | officer: Chief Financial Officer | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| GUDONIS PAUL R | director, officer: Chief Executive Officer | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| KIRK THOMAS F | director | 2025-06-11 | A-Award | 0 | 2025-06-12 |
| Crowley Thomas Aloysius Jr. | director | 2025-06-11 | A-Award | 0 | 2025-06-12 |
| Morris Milton Mayo | director | 2025-06-11 | A-Award | 0 | 2025-06-12 |
| Getz Heather C | director | 2025-06-11 | A-Award | 0 | 2025-06-12 |
| Kovelman Harry | officer: Chief Medical Officer | 2025-06-06 | F-InKind | 2.97 | 2025-06-06 |
| HENRY DAVID A | officer: Chief Financial Officer | 2025-06-06 | F-InKind | 2.97 | 2025-06-06 |
| KIRK THOMAS F | director | 2025-05-15 | P-Purchase | 3.25 | 2025-05-15 |
| KIRK THOMAS F | director | 2025-05-14 | P-Purchase | 3.25 | 2025-05-15 |
| GUDONIS PAUL R | director, officer: Chief Executive Officer | 2025-05-15 | P-Purchase | 3.2204 | 2025-05-15 |
| KIRK THOMAS F | director | 2025-05-12 | P-Purchase | 3.35 | 2025-05-14 |
| Mitchell Micah | officer: Chief Commercial Officer | 2025-03-14 | S-Sale | 5.1576 | 2025-03-21 |
| KIRK THOMAS F | director | 2025-03-13 | P-Purchase | 5 | 2025-03-14 |
| Mitchell Micah | officer: Chief Commercial Officer | 2025-03-14 | S-Sale | 5.1576 | 2025-03-14 |
| Mitchell Micah | officer: Chief Commercial Officer | 2025-03-11 | A-Award | 0 | 2025-03-14 |
| Kovelman Harry | officer: Chief Medical Officer | 2025-03-11 | A-Award | 0 | 2025-03-13 |
| Kovelman Harry | officer: Chief Medical Officer | 2025-03-12 | S-Sale | 5.5006 | 2025-03-13 |
| Kovelman Harry | officer: Chief Medical Officer | 2025-03-13 | F-InKind | 5.22 | 2025-03-13 |
| GUDONIS PAUL R | director, officer: Chief Executive Officer | 2025-03-11 | A-Award | 0 | 2025-03-13 |
| HENRY DAVID A | officer: Chief Financial Officer | 2025-03-11 | A-Award | 0 | 2025-03-13 |
| HENRY DAVID A | officer: Chief Financial Officer | 2025-03-13 | F-InKind | 5.22 | 2025-03-13 |
| Mitchell Micah | officer: Chief Commercial Officer | 2024-03-11 | A-Award | 0 | 2025-03-13 |
| Mitchell Micah | officer: Chief Commercial Officer | 2025-03-13 | F-InKind | 5.22 | 2025-03-13 |
| GUDONIS PAUL R | director, officer: Chief Executive Officer | 2025-02-13 | M-Exempt | 0.048 | 2025-02-18 |
| GUDONIS PAUL R | director, officer: Chief Executive Officer | 2025-02-13 | M-Exempt | 0.048 | 2025-02-18 |
| Mitchell Micah | officer: Chief Commercial Officer | 2024-06-09 | M-Exempt | 0 | 2025-01-24 |
| Mitchell Micah | officer: Chief Commercial Officer | 2024-06-09 | M-Exempt | 0 | 2025-01-24 |
| HENRY DAVID A | officer: Chief Financial Officer | 2024-06-09 | M-Exempt | 0 | 2025-01-24 |
| HENRY DAVID A | officer: Chief Financial Officer | 2024-06-09 | M-Exempt | 0 | 2025-01-24 |
| Kovelman Harry | officer: Chief Medical Officer | 2024-06-09 | M-Exempt | 0 | 2025-01-24 |
| Kovelman Harry | officer: Chief Medical Officer | 2024-06-09 | M-Exempt | 0 | 2025-01-24 |
| GUDONIS PAUL R | director, officer: Chief Executive Officer | 2024-06-09 | M-Exempt | 0 | 2025-01-24 |
| GUDONIS PAUL R | director, officer: Chief Executive Officer | 2024-06-09 | M-Exempt | 0 | 2025-01-24 |
| GUDONIS PAUL R | director, officer: Chief Executive Officer | 2024-06-05 | A-Award | 0 | 2025-01-22 |
| Kovelman Harry | officer: Chief Medical Officer | 2024-11-04 | F-InKind | 3.7 | 2024-11-05 |
| Kovelman Harry | officer: Chief Medical Officer | 2024-10-03 | F-InKind | 3.86 | 2024-10-04 |
| Kovelman Harry | officer: Chief Medical Officer | 2024-09-05 | S-Sale | 3.7586 | 2024-09-09 |
| Kovelman Harry | officer: Chief Medical Officer | 2024-09-03 | S-Sale | 4.012 | 2024-09-05 |
| Kovelman Harry | officer: Chief Medical Officer | 2024-09-04 | F-InKind | 3.89 | 2024-09-05 |
| Kovelman Harry | officer: Chief Medical Officer | 2024-08-05 | F-InKind | 3.96 | 2024-08-07 |
| Kovelman Harry | officer: Chief Medical Officer | 2024-07-03 | F-InKind | 2.85 | 2024-07-08 |
| Mitchell Micah | officer: Chief Commercial Officer | 2024-06-10 | F-InKind | 3.377 | 2024-07-02 |
| Kovelman Harry | officer: Chief Medical Officer | 2024-06-10 | F-InKind | 3.379 | 2024-07-02 |
| Mitchell Micah | officer: Chief Commercial Officer | 2024-07-01 | F-InKind | 3.02 | 2024-07-02 |
| Kovelman Harry | officer: Chief Medical Officer | 2024-07-01 | F-InKind | 3.02 | 2024-07-02 |
| HENRY DAVID A | officer: Chief Financial Officer | 2024-07-01 | F-InKind | 3.02 | 2024-07-02 |
| HENRY DAVID A | officer: Chief Financial Officer | 2024-06-10 | F-InKind | 3.376 | 2024-06-12 |
| Kovelman Harry | officer: Chief Medical Officer | 2024-06-10 | F-InKind | 3.379 | 2024-06-12 |
| Mitchell Micah | officer: Chief Commercial Officer | 2024-06-10 | F-InKind | 3.377 | 2024-06-12 |
| HENRY DAVID A | officer: Chief Financial Officer | 2024-06-05 | A-Award | 0 | 2024-06-07 |